| Todd Harrison Beckstead, MD | |
|
419 S Washington St, Suite 102, Casper, WY 82601-2951 | |
| (307) 577-4220 | |
| (307) 235-0931 |
| Full Name | Todd Harrison Beckstead |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 30 Years |
| Location | 419 S Washington St, Casper, Wyoming |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336135763 | NPI | - | NPPES |
| 0069870 | Medicaid | MT | |
| 020043010 | Other | WY | RAILROAD MEDICARE |
| 0575142 | Medicaid | IA | |
| 01155342 | Medicaid | CO | |
| 308059 | Other | WY | BLUE CROSS BLUE SHIELD |
| 114484700 | Medicaid | WY | |
| 8359366 | Medicaid | WA | |
| W308059 | Other | WY | WYOMING MEDICARE |
| 520883072 | Medicaid | NE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 6214A (Wyoming) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wyoming Medical Center | Casper, WY | Hospital |
| Summit Medical Center | Casper, WY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wyoming Surgical Associates Pc | 3375525017 | 6 |
News Archive
A controversial treatment for autism spectrum disorder (ASD) is not only ineffective but may be harmful, according to a study conducted by Baylor University researchers.
A new treatment that delivers a freezing or near-freezing temperature to the back of the nose of patients can offer relief to people suffering from chronic stuffy or runny nose, postnasal drip and cough. These symptoms result from persistently inflamed nose and sinuses, a condition known as chronic rhinitis.
AstraZeneca today announced the start of a Phase III study (FALCON), a global clinical trial which will involve 450 postmenopausal patients with hormone receptor-positive locally advanced or metastatic breast cancer who have not previously been treated with any hormonal therapy. The Phase III study is designed to evaluate the efficacy and tolerability of fulvestrant 500 mg compared to anastrozole 1 mg in this patient population.
Kessler Foundation scientists have identified predictors of prospective memory impairment after traumatic brain injury (TBI). Findings were epublished on July 28 by the Journal of the International Neuropsychological Society.
› Verified 6 days ago
| Entity Name | Wyoming Surgical Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598751075 PECOS PAC ID: 3375525017 Enrollment ID: O20040604000889 |
News Archive
A controversial treatment for autism spectrum disorder (ASD) is not only ineffective but may be harmful, according to a study conducted by Baylor University researchers.
A new treatment that delivers a freezing or near-freezing temperature to the back of the nose of patients can offer relief to people suffering from chronic stuffy or runny nose, postnasal drip and cough. These symptoms result from persistently inflamed nose and sinuses, a condition known as chronic rhinitis.
AstraZeneca today announced the start of a Phase III study (FALCON), a global clinical trial which will involve 450 postmenopausal patients with hormone receptor-positive locally advanced or metastatic breast cancer who have not previously been treated with any hormonal therapy. The Phase III study is designed to evaluate the efficacy and tolerability of fulvestrant 500 mg compared to anastrozole 1 mg in this patient population.
Kessler Foundation scientists have identified predictors of prospective memory impairment after traumatic brain injury (TBI). Findings were epublished on July 28 by the Journal of the International Neuropsychological Society.
› Verified 6 days ago
| Entity Name | Banner Health Physicians West Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063778728 PECOS PAC ID: 5092978866 Enrollment ID: O20120607000123 |
News Archive
A controversial treatment for autism spectrum disorder (ASD) is not only ineffective but may be harmful, according to a study conducted by Baylor University researchers.
A new treatment that delivers a freezing or near-freezing temperature to the back of the nose of patients can offer relief to people suffering from chronic stuffy or runny nose, postnasal drip and cough. These symptoms result from persistently inflamed nose and sinuses, a condition known as chronic rhinitis.
AstraZeneca today announced the start of a Phase III study (FALCON), a global clinical trial which will involve 450 postmenopausal patients with hormone receptor-positive locally advanced or metastatic breast cancer who have not previously been treated with any hormonal therapy. The Phase III study is designed to evaluate the efficacy and tolerability of fulvestrant 500 mg compared to anastrozole 1 mg in this patient population.
Kessler Foundation scientists have identified predictors of prospective memory impairment after traumatic brain injury (TBI). Findings were epublished on July 28 by the Journal of the International Neuropsychological Society.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Todd Harrison Beckstead, MD 419 S Washington St, Suite 102, Casper, WY 82601-2951 Ph: (307) 577-4220 | Todd Harrison Beckstead, MD 419 S Washington St, Suite 102, Casper, WY 82601-2951 Ph: (307) 577-4220 |
News Archive
A controversial treatment for autism spectrum disorder (ASD) is not only ineffective but may be harmful, according to a study conducted by Baylor University researchers.
A new treatment that delivers a freezing or near-freezing temperature to the back of the nose of patients can offer relief to people suffering from chronic stuffy or runny nose, postnasal drip and cough. These symptoms result from persistently inflamed nose and sinuses, a condition known as chronic rhinitis.
AstraZeneca today announced the start of a Phase III study (FALCON), a global clinical trial which will involve 450 postmenopausal patients with hormone receptor-positive locally advanced or metastatic breast cancer who have not previously been treated with any hormonal therapy. The Phase III study is designed to evaluate the efficacy and tolerability of fulvestrant 500 mg compared to anastrozole 1 mg in this patient population.
Kessler Foundation scientists have identified predictors of prospective memory impairment after traumatic brain injury (TBI). Findings were epublished on July 28 by the Journal of the International Neuropsychological Society.
› Verified 6 days ago
Lane Lester Smothers, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 419 S Washington St, Suite 102, Casper, WY 82601 Phone: 307-577-4220 Fax: 307-235-0931 | |
Dr. Abdul Qader Sufyan Alarhayem, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 419 S Washington St Ste 101, Casper, WY 82601 Phone: 307-577-1003 | |
James Allen Anderson, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 419 S Washington St, Suite 102, Casper, WY 82601 Phone: 307-577-4220 Fax: 307-235-0931 | |
Dr. Richard M. Jaouen, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1129 E 2nd St, Casper, WY 82601 Phone: 307-472-4300 Fax: 307-265-7479 | |
Mary E Macguire, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1450 E A St, Ste 3, Casper, WY 82601 Phone: 307-473-7821 Fax: 307-473-7522 | |
Dr. Benjamin C Kautza, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1233 E 2nd St, Casper, WY 82601 Phone: 414-719-2959 |